CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state-of-the art production facilities.

Press Releases

CV Sciences, Inc. to Webcast Live at VirtualInvestorConferences.com June 1, 2017

Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual VirtualInvestorConferences.com

LAS VEGAS, NV – May 30, 2017 /PRNewswire/ — CV Sciences, Inc. (OTCQB: CVSI), today announced that Chief Financial Officer, Joseph Dowling, will present live at VirtualInvestorConferences.com on June 1, 2017.

DATE: Thursday,  June 1, 2017

TIME: 11:30 AM EDT

LINK: https://tinyurl.com/0601prepr

This will be a live, interactive online event where investors are invited to ask the company questions in real-time – both in the presentation hall as well as the association’s “virtual trade booth.” If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.

It is recommended that investors pre-register and run the online system check to save time and receive event updates.

Learn more about the event at www.VirtualInvestorConferences.com.

Recent Company Highlights

  • – CV Sciences, Inc. will meet with the Food and Drug Administration (FDA) in June 2017 to discuss its initial drug candidate (CVSI-007).
  • – In March 2017, CV Sciences, Inc. announced its first online education platform designed to enhance its brand education and advocacy through Experticity.
  • – CV Sciences. Inc. appointed Dr. Stephen M. Schmitz to its Board of Directors to help move drug development program forward to commercialization.


About CV Sciences, Inc.

CV Sciences, Inc. (OTCQB:CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and, a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. CV Sciences, Inc. has primary offices and facilities in Las Vegas, Nevada and San Diego, California. Additional information is available from OTCMarkets.com or by visiting www.cvsciences.com.

About VirtualInvestorConferences.com

Since 2010, VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PRNewswire, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire’s leading-edge online conferencing and investor communications capabilities with BetterInvesting’s extensive retail investor audience network.

Leave a Reply

Your email address will not be published. Required fields are marked *